Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

HUGE FSD Pharma Inc

0,3198

0,0048 (1,52%)

Zuletzt aktualisiert: 19:13:35

Verzögert um 15 Minuten

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

nullnull

FSD Pharma (NASDAQ:HUGE)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more FSD Pharma Charts.

FSD Pharma (NASDAQ:HUGE)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more FSD Pharma Charts.

News FSD Pharma Inc

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 16 Mai 2024 (1 Tag vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 20 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

GBB Maintains Strong Position in its Ongoing Lawsuit with FSD Pharma After Court Refuses to Dismiss Case
Donnerstag 11 Januar 2024 (4 Monate vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Freitag 5 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

InvestmentPitch Media Video Discusses FSD Pharma’s Continued Development of its Exciting New Rapid Detox Drink UNBUZZD™, with Video Comments from Kevin Harrington
Freitag 22 September 2023 (8 Monate vor) • GlobeNewswire Inc.

FSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. Trading under the symbol (NASDAQ: JUPW)
Samstag 26 August 2023 (9 Monate vor) • Business Wire

InvestmentPitch Media Video Features FSD Pharma’s Definitive Agreement Granting Exclusive Rights for Launch of UNBUZZD, a Revolutionary Rapid Alcohol Detoxification Drink
Donnerstag 3 August 2023 (9 Monate vor) • GlobeNewswire Inc.

Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201
Montag 17 Juli 2023 (10 Monate vor) • Business Wire

FSD Pharma Retains Christian Attar Law and Team of Experts to Lead Preliminary Investigation of Possible Naked Short Selling and Manipulation in its stock
Montag 10 Juli 2023 (10 Monate vor) • Business Wire

FSD Pharma Appoints Zeeshan Saeed as Chief Executive Officer, Anthony Durkacz to Serve as Executive Co-Chairman of the Board of Directors
Dienstag 4 Juli 2023 (10 Monate vor) • Business Wire

FSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders
Freitag 30 Juni 2023 (11 Monate vor) • Business Wire

InvestmentPitch Media Video Discusses FSD Pharma’s Granting of Exclusive Rights to Revolutionary Recreational Alcohol Misuse Technology to Celly Nutrition
Freitag 23 Juni 2023 (11 Monate vor) • GlobeNewswire Inc.

Weitere FSD Pharma Inc News-Artikel

JP Morgan Chase

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen